학술논문
Translational pharmacokinetic-pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose
Document Type
Article
Author
Source
In: CPT: Pharmacometrics and Systems Pharmacology . (CPT: Pharmacometrics and Systems Pharmacology, May 2021, 10(5):428-440)
Subject
Language
English
ISSN
21638306